DRAXXIN DIN 02285452
Health Canada record
| Active ingredient(s) | TULATHROMYCIN 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 19-Sep-2006 |
| Current status date | 07-Oct-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TULATHROMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532859 | AROVYN | INTERVET CANADA CORP | Solution | TULATHROMYCIN 100 MG | Approved |
| 02430711 | DRAXXIN 25 | ZOETIS CANADA INC | Solution | TULATHROMYCIN 25 MG | Marketed |
| 02516683 | DRAXXIN KP | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG; KETOPROFEN 120 MG | Marketed |
| 02516500 | INCREXXA | ELANCO CANADA LIMITED | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02508990 | LYDAXX | VETOQUINOL N A INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02544229 | MACROSYN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536013 | TULAJECT | ALIVIRA ANIMAL HEALTH LIMITED | Solution | TULATHROMYCIN 100 MG | Approved |
| 02502151 | TULAVEN | CEVA ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02530155 | TULINOVET | MODERN VETERINARY THERAPEUTICS LLC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02502879 | TULISSIN | VIRBAC AH, INC. | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536277 | TULISSIN 25 | VIRBAC AH, INC. | Solution | TULATHROMYCIN 25 MG | Approved |
| 02560348 | VACASAN | PARNELL TECHNOLOGIES PTY LTD | Solution | TULATHROMYCIN 100 MG | Approved |
| 02518236 | REXXOLIDE | DECHRA REGULATORY BV | Solution | TULATHROMYCIN 100 MG | Dormant |
| 02505401 | TULIEVE | NORBROOK LABORATORIES LTD. | Solution | TULATHROMYCIN 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22520 | 2019-08-12 | Supplement to a New Drug Submission (SNDS) | ADDITION OOF DRUG PRODUCT MANUFACTURING SITE |
| 21253 | 2018-09-04 | Supplement to a New Drug Submission (SNDS) | NEW SPECIES: SHEEP |
| 18504 | 2016-09-23 | Supplement to a New Drug Submission (SNDS) | MODIFICATION TO THE INDICATION AND WARNINGS STATEMENT |
| 14951 | 2013-11-27 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION (DIN) NUMBER |
| 10666 | 2009-10-16 | Supplement to a New Drug Submission (SNDS) | Additional indication |
| 10027 | 2009-02-04 | Supplement to a New Drug Submission (SNDS) | New indication: For the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii |
| 9975 | 2008-12-23 | Supplement to a New Drug Submission (SNDS) | Additional indications |
| 8238 | 2006-08-31 | New Drug Submission (NDS) |